20.63
20.63 (0%)
As of Apr 25, 2025
Castle Biosciences Inc [CSTL]
Source:
Company Overview
Castle Biosciences Inc is a molecular diagnostics company offering innovative test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus, uveal melanoma, and in the treatment of mental health conditions.
| Country | United States |
| Headquarters | friendswood, texas |
| Phone Number | 866-788-9007 |
| Industry | services |
| CEO | Derek J. Maetzold |
| Website | www.castlebiosciences.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $332.1 |
| Operating Profit | $8.7 |
| Net Income | $18.2 |
| Net Cash | $20.9 |
Profit Ratios
| Gross Margin | $271.9 |
| Operating Margin | 2.6 |
| Profit as % of Revenues | 1,490.1% |
| Profit as % of Assets | 3.7% |
| Profit as % of Stockholder Equity | 4% |
Management Effectiveness
| Return on Equity | 4% |
| Return on Assets | 3.4% |
| Turnover Ratio | 67.5% |
| EBITA | $19.8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $531.2 |
| Total Liabilities | $75.4 |
| Operating Cash Flow | $64.9 |
| Investing Cash Flow | $-50.1 |
| Financing Cash Flow | $6.1 |
